Skip to main content
. 2018 Oct 19;8(2):e1527498. doi: 10.1080/2162402X.2018.1527498

Figure 4.

Figure 4.

Analysis of activating receptors on NK cell subsets in NSCLC patients.

Proportions of (A) NKG2D+, (B) NKp30+, (C) NKp44+ and (D) NKp46+ among total, CD56dim CD16+, CD56dim CD16 and CD56bright NK cell subsets in HD (grey n = 41) and NSCLC patients (black n = 176). Red bars represent the mean of each group. Statistical analysis were performed using the Mann-Whitney test (ns = not significant; * < 0.05; ** < 0.01; *** < 0.001; **** < 0.0001).